Skip to main content
SpringerLink
Log in

High Ligation of Inferior Mesenteric Artery: A Standard Procedure for Colorectal Cancer?

  • Colorectal Cancer
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Augestad KM, Lindsetmo RO, Reynolds H, et al. International trends in surgical treatment of rectal cancer. Am J Surg. 2011;201(3):353–7, discussion 357–8.

    Article  PubMed  Google Scholar 

  2. Kang J, Hur H, Min BS, Kim NK, Lee KY. Prognostic impact of inferior mesenteric artery lymph node metastasis in colorectal cancer. Ann Surg Oncol. 2011;18(3):704–10.

    Article  PubMed  Google Scholar 

  3. Alberts SR, Sargent DJ, Smyrk TC, et al. Adjuvant mFOLFOX6 with or without cetuximab (Cmab) in KRAS wild-type (WT) patients (pts) with resected stage III colon cancer (CC): results from NCCTG Intergroup Phase III Trial N0147. J Clin Oncol. 2010;28(18 Suppl) (Abstract CRA3507).

  4. Green ED, Guyer MS. National human genome research institute. Charting a course for genomic medicine from base pairs to bedside. Nature 2011;470(7333):204–13.

    Article  PubMed  CAS  Google Scholar 

  5. Roukos DH. Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics. 2010;11(8):1039–43.

    Article  PubMed  CAS  Google Scholar 

  6. Roukos DH. Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice. Biomark Med. 2010;4(4):583–6.

    Article  PubMed  Google Scholar 

  7. Roukos DH, Katsios C, Liakakos T. Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn. 2010;10(5):541–5.

    Article  PubMed  CAS  Google Scholar 

  8. Roukos DH. Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn. 2010;10(3):247–50.

    Article  PubMed  Google Scholar 

  9. Roukos DH. Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks. Pharmacogenomics J. 2011;11(2):81–92.

    Article  PubMed  CAS  Google Scholar 

  10. Roukos DH. Next-generation sequencing and epigenome technologies: potential medical applications. Expert Rev Med Devices. 2010;7(6):723–6.

    Article  PubMed  CAS  Google Scholar 

  11. Katsios C, Roukos DH. Individual genomes and personalized medicine: life diversity and complexity. Per Med. 2010;7(4):347–50.

    Article  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Third Department of Surgery, University of Athens, School of Medicine, Attikon University Hospital, Chaidari, Athens, Greece

    Theodore Liakakos MD

Authors
  1. Theodore Liakakos MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Theodore Liakakos MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liakakos, T. High Ligation of Inferior Mesenteric Artery: A Standard Procedure for Colorectal Cancer?. Ann Surg Oncol 18 (Suppl 3), 240–241 (2011). https://doi.org/10.1245/s10434-011-1883-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-011-1883-0

Keywords

Search

Navigation